REGN475 (SAR164877)

SAR164877 · Regeneron Pharmaceuticals

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for REGN475 (SAR164877), covering 2011-04-19 to 2013-05-27. Get the full timeline:

Most recent: Clinical Trial Update: Single Injection of REGN475/SAR164877 in the Treatment of Chronic Pancreatitis Pain [Phase 2]